New research from Stockholm University and Karolinska Institutet shows that viruses interact with proteins in the biological fluids of their host which results in a layer of proteins on the viral surface. This coat of proteins makes the virus more infectious and facilitates the formation of plaques characteristic of neurodegenerative diseases such as Alzheimer’s disease.
Are viruses dead or alive? Well… both. Viruses can only reproduce inside living cells and exploit the cellular machinery of their host to their benefit. However, before entering a host cell, viruses are just nanometer-sized particles, very similar to artificial nanoparticles used in medical applications for diagnosis and therapy. Scientists from Stockholm University and Karolinska Institutet have found that viruses and nanoparticles share another important property; they both become covered by a layer of proteins when they encounter the biological fluids of their host before they find their target cell. This layer of proteins on the surface influence their biological activity significantly.
“Imagine a tennis ball falling into a bowl of milk and cereals. The ball is immediately covered by the sticky particles in the mix and they remain on the ball when you take it out of the bowl. The same thing happens when a virus gets in contact with blood or lung fluids that contain thousands of proteins. Many of these proteins immediately stick to the viral surface forming a so-called protein corona”, Kariem Ezzat of Stockholm University and Karolinska Institutet explains.
Kariem Ezzat and his colleagues studied the protein corona of respiratory syncytial virus (RSV) in different biological fluids. RSV is the most common cause of acute lower respiratory tract infections in young children worldwide, leading up to 34 million cases and 196,000 fatalities each year. “The protein corona signature of RSV in the blood is very different from that in lung fluids. It is also different between humans and other species such as rhesus macaque monkeys, which also can be infected with RSV”, Kariem Ezzat says. “The virus remains unchanged on the genetic level. It just acquires different identities by accumulating different protein coronae on its surface depending on its environment. This makes it possible for the virus to use extracellular host factors for its benefit, and we’ve shown that many of these different coronae make RSV more infectious.”
The researchers from Stockholm University and Karolinska Institutet have also found that viruses such as RSV and herpes simplex virus type 1 (HSV-1) can bind a special class of proteins called amyloid proteins. Amyloid proteins aggregate into plaques that play a part in Alzheimer’s disease where they lead to neuronal cell death. The mechanism behind the connection between viruses and amyloid plaques has been hard to find till now, but Kariem Ezzat and his colleagues found that HSV-1 is able to accelerate the transformation of soluble amyloid proteins into thread-like structures that constitute the amyloid plaques. In animal models of Alzheimer’s disease, they saw that mice developed the disease within 48 hours of infection in the brain. In absence of an HSV-1 infection the process normally takes several months.
“The novel mechanisms described in our paper can have an impact not only on understanding new factors determining how infectious a virus is, but also on devising new ways to design vaccines. In addition, describing a physical mechanism that links viral and amyloid causes of disease adds weight to the increasing research interest in the role of microbes in neurodegenerative disorders such as Alzheimer’s disease and opens up new avenues for treatments.”, Kariem Ezzat of Stockholm University and Karolinska Institutet says.
The Latest on: Neurodegenerative diseases
via Google News
The Latest on: Neurodegenerative diseases
- Motor neuron disease inflammation trigger discoveredon October 7, 2020 at 8:08 pm
In collaboration with colleagues at the Walter and Eliza Hall Institute (WEHI) and the University of Melbourne, Hudson Institute scientists have ...
- Damage Done by Alzheimer’s Risk Gene May Be Undone by Another Disease-Linked Geneon October 6, 2020 at 11:07 am
New research suggests that the most significant risk-gene associated with Alzheimer’s disease can hinder a crucial process in a specific type of brain cell — and the key to alleviating the ...
- The Regenesis Project Investigates a New Treatment Possibility for Dementia, Alzheimer's and Parkinson's Diseaseon October 6, 2020 at 6:25 am
The pursuit of an effective therapeutic intervention for dementia has inspired interest in the class of medications known as tyrosine kinase inhibitors ...
- Apellis initiates mid-stage pegcetacoplan studies in rare kidney and neurological diseaseson October 5, 2020 at 10:01 am
(NASDAQ:APLS) has initiated registrational programs of pegcetacoplan for C3 glomerulopathy (C3G) or immune complex membranoproliferative glomerulonephritis (IC-MPGN), rare kidney diseases, and ...
- Ionis' Alexander Disease Candidate Gets Orphan Drug Statuson October 2, 2020 at 9:18 am
IONS announced that the FDA has granted an orphan drug designation to its investigational pipeline candidate ION373, which is being developed for the treatment of people with Alexander disease, a rare ...
- IntraBio Reports Positive Data from IB1001 Multinational Clinical Trial for the Treatment of Niemann-Pick disease Type Con October 1, 2020 at 4:06 am
Positive results reported from IntraBio's multinational clinical trial with IB1001 for treatment of Niemann-Pick disease Type C (NPC) Statistically significant and clinically meaningful improvement ...
- Ionis's ION373 an Orphan Drug in U.S. for a rare neurodegenerative diseaseon September 30, 2020 at 6:13 pm
The FDA has designated Orphan Drug status to Ionis Pharmaceuticals's (NASDAQ:IONS) ION373 for the treatment of Alexander disease, a rare neurodegenerative disease, characterized by the destruction of ...
- Too much sugar in your diet could result in this devastating neurodegenerative diseaseon September 30, 2020 at 11:29 am
When consumed in excess, (especially via processed sugars) fructose metabolism in the brain deprives the body of the cerebral energy it needs to perform other important neurological functions.
- How the brain's immune cells could guide treatment of neurodegenerative diseaseson September 30, 2020 at 8:00 am
Human behavior relies on the excitation and inhibition of neurons, and it's the neurons themselves that are largely responsible for keeping this circuit of activity in balance. But now a research team ...
- Effect of Environmental Toxicants on Developing Neurodegenerative Conditionson September 30, 2020 at 2:32 am
An article has discussed the impact of environmental toxicants amongst the role of a healthy diet, lifestyle improvement, and nutraceuticals.
via Bing News